31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
A controversial bill passed by the California legislative assembly's preliminary vote on September 1...
Read More >
...Construction industry forecasts are difficult in a “normal year” (remember those?), let alone a...
Read More >
Lawmakers have begun to hold a series of hearings to discuss the “future of work,” and it may be n...
Read More >
Next month, Connecticut legislators from across the political spectrum are set to formally introduce...
Read More >
Back in 2016, the government commissioned the Hampton-Alexander Review to address gender inequality ...
Read More >
On June 4 and June 5, 2019, two different Appellate Division panels issued opinions discussing the e...
Read More >